EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Essity AB Series A (0RQC) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of Essity AB Series A SEK 192, price SEK 261, upside -26.4%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Industrials · GB

EA Thin data Sep 29, 2026

Essity AB Series A

0RQC · LSE

Weak valuationQuality is weak on top of the rich price.

!Fair value kr 191.88 · Overvalued (−26.4%)
!Quality 49/100
!Weak Growth (revenue 3y +0.9 %/yr)
!Thin margins · 8.8% net margin (TTM)
!Moderate debt
✓3.4% dividend yield · Sustainable
✓Ranks above peers (6/10)
!Moderate moat 52/100
!Insider activity 45/100
!Evidence only low, so the estimate is less certain
!Weak on future: 13 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 301.73 kr 168.92 Fair Value kr 191.88 Sep 2017 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.

How to read this chart

60‑month range kr 168.92 – kr 301.73 · fair‑value band kr 116.42 – kr 294.10 · the kr 260.75 price screens above the kr 191.88 fair value. Dashed = 300-day average. As of Sep 29, 2026.

Follow Essity AB Series A in your weekly email

Every Wednesday you see whether Essity AB Series A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene.

Show more

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce. The Consumer Goods segment provides pads, panty liners, tampons, diapers, wet wipes, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Libresse, Bodyform, Nana, Saba, Nosotras, TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, and Familia brands through retail trade and e-commerce. The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, airports, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.

Stock analysis

Essity AB Series A (0RQC) currently trades at kr 260.75, while our model-based Fair Value estimate is kr 191.88, 26.4% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of kr 208.64 per share, and 2 of the 23 models we run sit above the kr 260.75 price.

Bear case: the Asset-Based group reads lowest at kr 57.12, and 21 of the 23 models stay below the price. Evidence for this calculation is low.

Scenario range: kr 116.42 (bear) to kr 294.10 (bull), the price of kr 260.75 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Essity AB Series A reported revenue of 122B SEK in FY2021 versus 109B SEK in FY2017, a compound +2.8%/yr. Reported net income was 8.6B SEK in FY2021, compounding +1.5%/yr from FY2017.

Key figures

Market cap 175B SEK (≈ $17.5B) · P/E ratio 0.3 · P/S ratio 0.02 · EPS (TTM) kr 9.67 · Dividend yield 3.4% · Net margin 7.1% · Return on equity 14.0% · Return on assets (EBIT) 8.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 7% below its 52-week high and 11% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at −26%, 0RQC screens cheaper than that median.

Fair Value models

Bear kr 116.42 Fair Value kr 191.88 Bull kr 294.10
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF kr 118.79 kr 186.07 kr 315.61 75
EPV kr 89.26 kr 114.47 kr 136.52 74
Growth DCF kr 126.71 kr 192.31 kr 308.43 73
All 23 models by family
DCF Models
FCF DCF kr 118.79 kr 186.07 kr 315.61 75
5Y Revenue Exit kr 104.29 kr 178.23 kr 287.54 67
5Y EBITDA Exit kr 166.04 kr 284.15 kr 443.06 70
5Y P/E Exit kr 109.63 kr 187.41 kr 282.04 66
10Y Revenue Exit kr 103.91 kr 163.71 kr 229.33 63
10Y EBITDA Exit kr 146.14 kr 231.08 kr 324.59 65
10Y P/E Exit kr 111.74 kr 169.54 kr 225.96 61
Earnings-Based
Graham-Dodd kr 83.46 kr 117.12 kr 136.87 65
EPV kr 89.26 kr 114.47 kr 136.52 74
Dividend Discount
Gordon GGM kr 64.27 kr 71.36 kr 81.29 67
DDM Multi-Stage kr 64.27 kr 82.84 kr 107.39 65
Multiples
P/E Multiple kr 193.30 kr 257.74 kr 322.17 63
P/S Multiple kr 156.48 kr 208.64 kr 260.81 58
P/B Multiple kr 156.48 kr 208.64 kr 260.81 55
EV/EBIT kr 177.62 kr 257.49 kr 337.36 65
EV/EBITDA kr 237.53 kr 337.37 kr 437.21 67
EV/Revenue kr 109.02 kr 182.32 kr 255.61 52
Asset-Based
NCAV (Graham) kr 42.62 kr 57.12 kr 85.25 54
Growth DCF
Growth DCF kr 126.71 kr 192.31 kr 308.43 73
Rev-Margin DCF kr 104.29 kr 182.41 kr 279.84 68
Economic Profit
Residual Income kr 84.10 kr 100.74 kr 129.64 73
ROIC Compounder kr 89.37 kr 118.22 kr 150.35 69
Growth Earnings
Growth-Adj P/E kr 136.50 kr 195.00 kr 253.50 65

Open the full fair value analysis →

Notify me when 0RQC reaches fair value

Put 0RQC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 49/100

Of which business quality 48 · Market factors (momentum, volatility) 58

Profitability 44
Margins and returns on capital today
Quality Growth 17
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 36
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 44
Price trend over the last 3–12 months (market factor)
52W Momentum 43
Distance to the 52-week high (market factor)

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+0.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.9% (2017) → 10.8% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
not computed

0RQC screens overvalued: fair value 26% below the price. Compare with NATHIND →

Compare Essity AB Series A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Paper Products” was too small, so the broader sector is used.)Industrials · 5305 stocks

Beats the sector median on 6/10 measures
Overall it ranks above its sector peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −26.4% · Below median
Profitability
Return on equity (TTM) 14.0% · Above median
Return on assets 6.6% · Top 25%
Net margin (TTM) 8.8% · Above median
Operating margin (TTM) 12.6% · Above median
Growth and dividend
Revenue growth 2.6% · Below median
Dividend yield (TTM) 3.4% · Above median
Balance sheet
Debt / equity 0.79× · Highest 25%

Valuation Multiplesvs Industrials median · lower = cheaper

P/E (TTM) 0.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 17
FUTURE (revenue growth)13 · sector 36
PAST (return on equity)56 · sector 29
HEALTH (low debt)60 · sector 94
DIVIDEND (yield)67 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Paper Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
NATHIND NATHIND ₹50.59 ₹61.65 +22%
GANGAPA GANGAPA ₹86.83 ₹25.19 −71%
MOHITPPR MOHITPPR ₹25.67 ₹70.35 +174%
CELLA CELLA ₹43.87 ₹17.27 −61%
KAYPOWR KAYPOWR ₹9.46 ₹3.75 −60%
SANPA SANPA ₹192.00 ₹234.99 +22%
SAFFRON SAFFRON ₹24.44 ₹11.48 −53%
Contemporary Amperex Technology Co 300750 ¥291.11 ¥695.24 +139%
Delta Electronics (Thailand) Public Company DELTA 263.00 THB 38.64 THB −85%
Larsen & Toubro Limited LT ₹3,876 ₹1,994 −49%

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Essity AB Series A Fair Value". https://www.fairvalue-calculator.com/stock/0RQC

Frequently asked questions

Is Essity AB Series A (0RQC) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of kr 191.88 versus the last price from Sep 25, 2026 of kr 260.75, about −26% upside (overvalued).
What is the fair value of 0RQC?
Our model-based fair value for Essity AB Series A is kr 191.88 (as of Sep 29, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): kr 260.75.
What is the quality score of 0RQC?
Essity AB Series A has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Essity AB Series A (0RQC)?
Our model-based price target is the fair value of kr 191.88 (as of Sep 29, 2026) from 23 valuation models. Cautious scenario kr 116.42, optimistic scenario kr 294.10. It is a calculation from audited fundamentals, not an analyst target.
What is the Essity AB Series A stock forecast for 2026?
Our models put fair value at kr 191.88, about −26% upside versus the last price from Sep 25, 2026 of kr 260.75 (overvalued). Cautious scenario kr 116.42, optimistic scenario kr 294.10. The calculation is refreshed regularly with new filings.
What is the revenue of Essity AB Series A (0RQC)?
Essity AB Series A reported trailing-twelve-month revenue of about 138B SEK (latest available figure, as of Sep 29, 2026).
Does Essity AB Series A pay a dividend?
Essity AB Series A currently shows a dividend yield of about 3.36% relative to its recent price (as of Sep 29, 2026).
What is the intrinsic value of Essity AB Series A (0RQC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Essity AB Series A it is kr 191.88 per share (as of Sep 29, 2026), against a price of kr 260.75. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Essity AB Series A stock overvalued or undervalued in 2026?
As of Sep 29, 2026, 0RQC trades above its calculated fair value: price kr 260.75, fair value kr 191.88, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0RQC?
No. The price is what the market pays today (kr 260.75); the fair value is what the company's own numbers justify (kr 191.88). For Essity AB Series A the two are kr 68.87 per share apart. That gap is exactly why we show both numbers side by side.
How much is Essity AB Series A worth?
The market values Essity AB Series A at about 175B SEK (market capitalisation, as of Sep 29, 2026). Per share that is kr 260.75; our models calculate a fair value of kr 191.88 per share.
What do the bullish and bearish scenarios say about 0RQC?
Our models span a range for Essity AB Series A: cautious scenario kr 116.42, base kr 191.88, optimistic kr 294.10 per share (as of Sep 29, 2026, price kr 260.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0RQC?
Essity AB Series A trades at a price-to-earnings ratio of 0.3 (as of Sep 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 191.88 is built from several models across several years.
How solid is the balance sheet of Essity AB Series A (0RQC)?
Balance-sheet figures for Essity AB Series A (as of Sep 29, 2026): return on equity 14.0%, debt of 0.79 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 0RQC from its 52-week high?
Essity AB Series A trades at kr 260.75, about 7% below its 52-week high of kr 281.50 and 11% above the low of kr 234.36 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of kr 191.88 is for.
Which stocks are comparable to Essity AB Series A?
From the same area (Industrials) we also value NATHIND, GANGAPA, MOHITPPR, CELLA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Essity AB Series A stock attractive at the current price?
The data as of Sep 29, 2026: price kr 260.75, calculated fair value kr 191.88 (−26%), Quality Score 49/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0RQC calculated?
We run Essity AB Series A through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 191.88, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Essity AB Series A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Essity AB Series A (0RQC)?
The latest price we hold is from Sep 25, 2026 and stands at kr 260.75. Our model-based fair value is kr 191.88, about −26% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Essity AB Series A right now?
Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 116.42 to kr 294.10) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Essity AB Series A

How large is the market capitalisation of Essity AB Series A (0RQC)?
The market capitalisation of Essity AB Series A is 175B SEK (≈ $17.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Essity AB Series A (0RQC)?
The price-to-sales ratio of Essity AB Series A is 0.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Essity AB Series A (0RQC)?
Earnings per share at Essity AB Series A are kr 9.67 (price ÷ EPS = P/E 0.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Essity AB Series A (0RQC)?
The dividend yield of Essity AB Series A is 3.4% (payout 90.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Essity AB Series A (0RQC)?
The net margin of Essity AB Series A is 7.1% (fiscal year 2021). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Essity AB Series A (0RQC)?
The return on equity (ROE) of Essity AB Series A is 14.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Essity AB Series A (0RQC)?
On an EBIT basis the return on assets of Essity AB Series A is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Essity AB Series A (0RQC)?
The operating margin of Essity AB Series A is 12.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Essity AB Series A (0RQC)?
Revenue at Essity AB Series A is growing +2.6% versus a year earlier (3y avg +0.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Essity AB Series A (0RQC)?
Earnings per share at Essity AB Series A are growing −10.3% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Essity AB Series A in the live analysis

One click puts Essity AB Series A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.